Skip to main content

Fluidigm Signs up Bioke as Benelux Distributor for BioMark

NEW YORK (GenomeWeb News) - Fluidigm said Thursday that under a new agreement the Dutch company Bioke is the exclusive distributor for Fluidigm’s BioMark PCR and genotyping system in the Netherlands, Luxembourg, and Belgium.
 
Fluidigm said the BioMark system offers performance improvements over standard RT-PCR systems because it is based on nanofluidic chips with preprogrammed fluidic networks that “automatically combine sets of samples with sets of PCR assays.”
 
The company said each BioMark array generates 2,304 PCR assays, but needs only 96 pipetting steps -- 1/40 the steps required by 384-well systems.
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.